J&J bolts higher after verdict in Oklahoma opioid case
Johnson & Johnson investors exhaled in relief Tuesday, pushing up the company’s shares after an Oklahoma judge imposed a $572 million verdict for the health care giant’s role in the nation’s opioid crisis. During the seven week trial, state prosecutors who sought up to $17 billion described J&J as a “kingpin” in an epidemic that’s […]
J&J bolts higher after verdict in Oklahoma opioid case Read More »
